Stay updated with breaking news from Nasdaq Bior. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report) saw a significant drop in short interest in November. As of November 30th, there was short interest totalling 293,000 shares, a drop of 55.2% from the November 15th total of 653,700 shares. Approximately 1.3% of the shares of the company are short sold. Based on an average […]
Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totalling 473,100 shares, a growth of 9.2% from the September 30th total of 433,300 shares. Currently, 2.2% of the shares of the company are short sold. Based […]
Biora Therapeutics (NASDAQ:BIOR – Get Free Report) and Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Analyst Recommendations This is a breakdown of current […]
Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report) was the recipient of a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 238,300 shares, a drop of 12.8% from the July 15th total of 273,300 shares. Based on an average daily volume of 183,800 shares, […]
Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Rating) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 390,700 shares, a decline of 7.7% from the April 30th total of 423,100 shares. Approximately 3.5% of the company’s shares are sold short. Based on an average […]